Humana Inc. $HUM Stock Holdings Lifted by PDT Partners LLC

Key Points

• PDT Partners LLC significantly increased its holdings in Humana Inc. by 229.9%, acquiring a total of 29,301 shares valued at approximately $7.75 million.
• Humana reported mixed quarterly earnings, with an EPS of $6.27 that fell short of expectations, but revenue increased by 9.6% year-over-year, reaching $32.39 billion.
• The company declared a quarterly dividend of $0.885 per share, which is part of a 1.2% yield, and its dividend payout ratio stands at 27.17%.

PDT Partners LLC lifted its holdings in Humana Inc. (NYSE:HUM - Free Report) by 229.9% during the first quarter, according to the company in its most recent filing with the SEC. The fund owned 29,301 shares of the insurance provider's stock after buying an additional 20,420 shares during the quarter. Humana makes up 0.6% of PDT Partners LLC's portfolio, making the stock its 16th biggest position. PDT Partners LLC's holdings in Humana were worth $7,753,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Cary Street Partners Investment Advisory LLC lifted its position in shares of Humana by 63.9% in the 1st quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider's stock worth $31,000 after buying an additional 46 shares during the last quarter. Riverview Trust Co bought a new stake in Humana in the 1st quarter valued at about $34,000. Garde Capital Inc. bought a new stake in Humana in the 1st quarter valued at about $36,000. Zions Bancorporation National Association UT bought a new stake in Humana in the 1st quarter valued at about $37,000. Finally, Whipplewood Advisors LLC lifted its position in Humana by 639.1% in the 1st quarter. Whipplewood Advisors LLC now owns 170 shares of the insurance provider's stock valued at $45,000 after purchasing an additional 147 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on HUM. Morgan Stanley cut their price objective on shares of Humana from $290.00 to $277.00 and set an "equal weight" rating on the stock in a research report on Thursday, July 31st. Piper Sandler cut their price objective on shares of Humana from $288.00 to $272.00 and set a "neutral" rating on the stock in a research report on Thursday, July 31st. Truist Financial cut their price objective on shares of Humana from $280.00 to $260.00 and set a "hold" rating on the stock in a research report on Wednesday, July 16th. Wall Street Zen downgraded shares of Humana from a "buy" rating to a "hold" rating in a research report on Saturday, August 2nd. Finally, Bank of America raised their target price on shares of Humana from $285.00 to $312.00 and gave the company a "neutral" rating in a research note on Tuesday. Seven research analysts have rated the stock with a Buy rating and sixteen have issued a Hold rating to the company. According to data from MarketBeat.com, Humana has a consensus rating of "Hold" and a consensus price target of $285.76.

Humana Price Performance

Shares of HUM traded up $2.16 during mid-day trading on Wednesday, hitting $312.22. The company's stock had a trading volume of 1,739,414 shares, compared to its average volume of 1,300,707. The firm has a 50-day moving average price of $258.71 and a 200 day moving average price of $255.72. The stock has a market capitalization of $37.55 billion, a price-to-earnings ratio of 23.96, a PEG ratio of 1.79 and a beta of 0.44. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.95 and a quick ratio of 1.95. Humana Inc. has a fifty-two week low of $206.87 and a fifty-two week high of $382.72.

Humana (NYSE:HUM - Get Free Report) last announced its quarterly earnings data on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share (EPS) for the quarter, missing the consensus estimate of $6.32 by ($0.05). The business had revenue of $32.39 billion during the quarter, compared to analyst estimates of $31.85 billion. Humana had a return on equity of 13.67% and a net margin of 1.28%.The business's revenue for the quarter was up 9.6% on a year-over-year basis. During the same period in the prior year, the firm earned $6.96 EPS. Humana has set its FY 2025 guidance at 17.000- EPS. On average, research analysts predict that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be paid a $0.885 dividend. The ex-dividend date of this dividend is Friday, September 26th. This represents a $3.54 annualized dividend and a dividend yield of 1.1%. Humana's payout ratio is currently 27.17%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.